EQUALINE  BACITRACIN ZINC- bacitracin zinc ointment 
Supervalu Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

equaline®
Bacitracin Zinc

Drug Facts

Active ingredient (each gram contains)

Bacitracin Zinc 500 units

Purpose

First aid antibiotic

Uses

first aid to help prevent infection in

Warnings

For external use only

Do not use

  • in the eyes
  • over large areas of the body
  • if you are allergic to any of the ingredients
  • longer than 1 week unless directed by a doctor

Ask a doctor before use

  • on deep or puncture wounds, animal bites, or serious burns

Stop use and ask a doctor if

  • condition persists or gets worse
  • a rash or other allergic reaction develops

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

mineral oil, white petrolatum

Questions?

Call 1-877-932-7948

DISTRIBUTED BY SUPERVALU INC.
EDEN PRAIRIE, MN 55344 USA

PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton

EQUALINE®

bacitracin zinc ointment USP
first aid antibiotic

NET WT 1 OZ (28.4g)

Principal Display Panel - 28.4 g Tube Carton
EQUALINE   BACITRACIN ZINC
bacitracin zinc ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41163-075
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Bacitracin Zinc (UNII: 89Y4M234ES) (Bacitracin - UNII:58H6RWO52I) Bacitracin500 [iU]  in 1 g
Inactive Ingredients
Ingredient NameStrength
mineral oil (UNII: T5L8T28FGP)  
petrolatum (UNII: 4T6H12BN9U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41163-075-021 in 1 CARTON
128.4 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333B05/11/2006
Labeler - Supervalu Inc (006961411)
Registrant - Taro Pharmaceuticals U.S.A., Inc. (145186370)
Establishment
NameAddressID/FEIBusiness Operations
Taro Pharmaceuticals Inc.206263295MANUFACTURE(41163-075)

Revised: 6/2015
Document Id: b74d8098-66f2-4103-a26d-fab7811748b7
Set id: c9d8d72c-b768-4192-9d1a-242a8a39a1c7
Version: 2
Effective Time: 20150623
 
Supervalu Inc